PharmaIP's profile picture. Learner, thinker, contributor, occasional anarchist

Pharma IP Strategies

@PharmaIP

Learner, thinker, contributor, occasional anarchist

Looking forward to this next week! www.ipcrys.com/twitter


Less than a week until Developing IP Strategies for Crystalline Forms www.ipcrys.com/twitter


New article - Counting the Cost of #Patent Expiration http://bit.ly/gLrZMW


Pharma IP Strategies reposted

What's the outlook for #pharma in 2011? My thoughts on patents, patients and prices (+ video and graphics) http://link.reuters.com/duk66q


Free Pharma IP articles, interviews etc http://bit.ly/aLZ3ne


Complimentary Pharma IP knowledge centre www.ipcrys.com/twitter


Pharma IP Strategies reposted

Enter this quick #Oncology Trials #Survey and let us know where you think the field is going http://bit.ly/978n8E #clinical #pharma


Pharma IP Strategies reposted

USPTO Proposes New Rules Intended to Streamline Appeals to the BPAI http://bit.ly/c2zhib


Recently filed biotech and pharma cases - http://bit.ly/a6EsIW


How to Address the IP Issues Specifically Associated with Polymorphic Forms - http://bit.ly/a8h2L1


Monday morning and freezing outside


Only a month to go! www.ipcrys.com/twitter


Pharma IP Strategies reposted

More Johnson & Johnson drug factories cited for terrible quality control: ... in Fort Washington that was respon... http://bit.ly/cadpao


New workshop: Optimising International Patent Protection For Crystalline Forms www.ipcrys.com/twitter


Anyone planning to go to this year's IP for Crystalline Forms conference?


USPTO Peer to Patent Program Expanded to Include Biotech Patent Applications:http://bit.ly/bajHGf


Free pharma IP/patent presentations as download - you need to scroll down to see all of them http://bit.ly/dpJFkJ


Great blog; www.patentdocs.org


Anyone planning to attend this year's Developing IP Strategies for Crystalline Forms? http://bit.ly/bMtYMb


Great podcast: How can polymorph patents increase cost efficiency?http://bit.ly/b8yg9D


United States Trends

Loading...

Something went wrong.


Something went wrong.